What Valensa International does

Valensa International, founded in 1999 as US Nutraceuticals and headquartered in Eustis, Florida, is a privately held B2B ingredient supplier specializing in clinically validated botanical and microalgae bioactives for the dietary supplement, functional food, cosmetics, and pet wellness industries. The company operates a fully integrated, USDA Organic, Kosher, and Halal-certified US manufacturing facility using proprietary Deep Extract® supercritical CO2 extraction technology to produce solvent-free extracts, paired with the O2B® Peroxidation Blocker stabilization system to extend shelf life up to four years. Valensa's product portfolio spans 11 branded ingredients including USPlus® (USP-verified saw palmetto), USPlus® PRO, Zanthin® (FDA NDI-approved natural astaxanthin), FlexPro® MD and FlexPro ES (joint health), Serevelle™ (hair health, launched 2025), Parry Organic Spirulina and Chlorella, SpiruZan®, Cran-Gyn, and Parry Greens for Pets.

The business generates revenue through direct B2B sales of bulk branded ingredients in multiple formats (oil, powder extracts, microencapsulated powders) to brand owners and formulators, supplemented by contract manufacturing/toll processing, custom product development services, and technology licensing arrangements. Distribution is global, supported by USP verification, FDA NDI approval, EU Novel Food authorization, Korean MFDS approval, and multiple international organic and quality certifications. Strategic input supply is secured through a 2008 exclusive partnership with EID Parry/Parry Nutraceuticals, a sister company operating 170-acre microalgae cultivation and manufacturing facilities in South India. Valensa maintains an active clinical research program with KOL collaborators in urology and dermatology, resulting in a peer-reviewed evidence portfolio that underpins the company's positioning as a science-driven ingredient partner for finished product brands.

Name

Valensa International

Legal name

Valensa International

Website

https://valensa.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Valensa International is a privately held B2B supplier of clinically validated, branded nutraceutical ingredients (saw palmetto, astaxanthin, microalgae, joint health, hair health) produced via proprietary supercritical CO2 extraction, serving dietary supplement, functional food, cosmetics, and pet wellness manufacturers globally.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Extracts, Oleoresins & Essential Oils (Spice Extracts for Flavoring) (AFAJANAJ)

akta.pro secondary industry

Phytogenics & Botanicals (Essential Oils, Plant Extracts) (AFADAKAF)

Keywords

• Botanical extract ingredients
• Nutraceutical ingredient supplier
• Supercritical CO2 extraction
• Clinically validated bioactives
• B2B dietary supplement ingredients

Headquarters

HQ city

Eustis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Bulk Ingredient Sales: Valensa generates revenue through the sale of proprietary branded ingredient solutions to dietary supplement, functional food, cosmetics, and pet wellness manufacturers. The company supplies ingredients in various formats (oil, powder extracts, microencapsulated powders) for use in softgels, capsules, gummies, beverages, and topical applications. Revenue is generated through direct B2B sales relationships with brand owners and formulators.
2. Contract Manufacturing / Toll Processing: Provides toll manufacturing and custom product development services using their proprietary extraction and formulation capabilities. Services include formulation design, feasibility testing, pilot production, and scale-up. Also offers advanced supercritical CO₂ extraction as a service to external partners.
3. Licensing and Technology Transfer: Licenses proprietary technologies and branded ingredients to partners. Examples include licensing Zanthin astaxanthin to Italian pharmaceutical company for eye health applications, and providing technology access for formulation partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Valensa International is a B2B supplier of branded, proprietary nutraceutical ingredients for human and pet wellness. It produces clinically validated bioactive ingredients using proprietary supercritical CO2 extraction (Deep Extract) and stabilization (O2B) technologies, supplying bulk ingredients in oil, powder, and microencapsulated formats to dietary supplement, functional food, cosmetics, and pet wellness manufacturers. The company also offers toll manufacturing, custom formulation, and analytical testing services.

Product overview

Valensa International is a B2B supplier of branded, proprietary nutraceutical ingredients focused on clinically proven, science-backed solutions for human and pet wellness. The portfolio includes SEREVELLE (hair health), USPlus PRO and USPlus (men's prostate and urinary health), FlexPro MD and FlexPro ES (joint health), Zanthin (natural astaxanthin antioxidant), Parry Organic Spirulina and Parry Organic Chlorella (plant-based superfoods), Cran-Gyn (women's urinary health), SpiruZan (combined algae superfood), and Parry Greens for Pets. The company offers ingredients in multiple formats (capsules, softgels, tablets, beverages, gummies, powders) and provides toll manufacturing, custom product development, and analytical testing services. All ingredients are produced using proprietary Deep Extract supercritical CO2 extraction and protected by O2B Peroxidation Blocker technology.

Differentiator

Problem solved

Functional benefit

Brands

• Serevelle: Proprietary bioactive fatty acids extract for hair health in women and men, powered by ActiLipid4Hair technology
• USPlus PRO
• Parry Organic Spirulina
• Zanthin
• USPlus
• FlexPro MD
• FlexPro ES
• Cran-Gyn
• SpiruZan
• Parry Organic Chlorella
• USPlus
• GEMS Supply Chain Excellence Program
• Deep Extract
• O2B Peroxidation Blocker

Products and services

• Serevelle First-ever proprietary bioactive fatty acids extract specifically designed for hair health in women and men, powered by ActiLipid4Hair technology. Clinically proven to deliver 12.8x more hair in 90 days. Sold as a bulk branded ingredient to cosmetics and dietary supplement manufacturers.
• USPlus PRO Next-generation, clinically proven ingredient for men's health addressing urinary performance, bladder control, and sexual function. Powered by proprietary free fatty acid-rich saw palmetto extract to address lower urinary tract symptoms and sexual function decline in men.
• Parry Organic Spirulina World's purest organic spirulina, a nutrient-rich microalgae for immunity and energy. First and only Spirulina to complete USP dietary ingredient verification program. Contains 2x to 3x more Phycocyanin, Carotenoids, and Chlorophyll than average spirulina with up to 70% high-quality protein.
• FlexPro MD Triple-action joint health formula that repairs joint tissue, resolves inflammation, and relieves joint discomfort. 3x to 5x more effective than glucosamine chondroitin at 350mg daily dose, formulated with phospholipid-bound Omega 3s, Zanthin Natural Astaxanthin, and Flexonic low molecular Hyaluronic Acid.
• Zanthin High purity natural astaxanthin complex extracted from Haematococcus pluvialis microalgae. Clinically proven at low 2-4mg doses for immune response, anti-inflammatory response, and healthy aging. 1.7x to 3.7x more bioavailable than commodity astaxanthin. First astaxanthin approved by FDA as New Dietary Ingredient.
• USPlus Only U.S. Pharmacopeia (USP) Verified lipidosterolic extract of Serenoa repens clinically studied to support men's prostate and urinary health. The only saw palmetto extract verified by USP for purity, potency, and identity.
• FlexPro ES Full spectrum joint health formula powered by Zanthin Natural Astaxanthin combined with proprietary low-molecular-weight hyaluronic acid and eggshell membrane. Delivers comprehensive joint comfort and mobility support through synergistic blend promoting joint tissue strength, flexibility, and natural repair processes.
• Cran-Gyn Comprehensive urinary tract health support for women combining cranberry juice extract containing proanthocyanidins (PAC) and natural D-Mannose. All-natural blend produced using proprietary formulation technology to prevent bacteria adherence to the bladder wall.
• SpiruZan Brain and body superfood combining Parry Organic Spirulina and Zanthin Natural Astaxanthin. Total brain and body superfood with rich source of Phycocyanin, Carotenoids, Chlorophyll, and GLA. Supports neurological, cardiovascular, immune and eye health.
• Parry Organic Chlorella Pure and potent natural detoxifier—single-celled green freshwater microalgae. Rich in high-quality protein, chlorophyll, dietary fiber, vitamins, minerals, and bioactive compounds. Contains high level of bioavailable Vitamin B12 clinically proven to increase serum Vitamin B12 levels by 5x in 90 days.
• Parry Greens for Pets Human-grade nutrition for pets using clinically proven ingredients Zanthin Natural Astaxanthin and Parry Organic Spirulina. Supports joint mobility, immune health, gut balance, and shiny coat. Available in chews, chewable tablets, functional treats, and premixes.
• Toll Manufacturing and Custom Formulation Services Contract manufacturing and custom product development services using proprietary extraction and formulation capabilities. Services include formulation design, feasibility testing, pilot production, scale-up, and advanced supercritical CO2 extraction as a service to external partners.

Quantifiable outcome

• Serevelle: 12.8x increase in hair density and fuller scalp coverage compared to placebo in 90 days; 7.8x greater increase in healthy, thicker hairs; 6x more new hair growth and follicle reactivation; 37% reduction in hair shedding vs baseline
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Dr. Glynis Ablon / Ablon Skin Institute & Research CentercoreStrategic or Co-development Partner · 1 January 2025Collaboration with leading dermatologist Dr. Glynis Ablon to design and conduct the first US-based human clinical study on proprietary bioactive fatty acids from saw palmetto (Serevelle) on women and men. Successfully completed first-ever US clinical study with results published in peer-reviewed journals.
• Monasterium Labs / QIMA (Germany)coreStrategic or Co-development Partner · 1 January 2023Collaboration established in 2023 with Monasterium Labs/QIMA in Germany to study Valensa's proprietary bioactive fatty acids in human hair follicle models. The partnership conducted breakthrough research proving potential for multi-modal benefits to address hair thinning and growth in women and men based on in vitro and ex vivo human hair follicle models.
• Leading Urologists (US, Canada, Europe)coreStrategic or Co-development Partner · 1 January 2018Valensa established a Center of Excellence for LSESr (lipidosterolic extract of serenoa repens) and collaborated with leading urologists from US, Canada, and Europe to drive innovation on bioactive free fatty acids for specific health benefits. This collaboration led to multiple landmark publications on saw palmetto efficacy for lower urinary tract symptoms (LUTS).
• EID Parry / Parry NutraceuticalscoreStrategic or Co-development Partner · 1 January 2008Strategic partnership forged in 2008 where Valensa became the exclusive distributor of Parry Organic Greens (spirulina and chlorella) in the USA. Parry is a sister company to Valensa with over 47 years of microalgae research and development experience since 1977. Parry manufactures organic spirulina and chlorella in 170-acre facilities in South India, and Valensa distributes these USP-verified organic products in the North American market.
• Italian Pharmaceutical Company (Zanthin Licensee)minorOEM/ Whitelabel/ Licensing Partner · 1 January 2006Licensing agreement established in 2006 where Valensa licensed its Zanthin astaxanthin to an Italian pharmaceutical company for pioneering research and application in eye health. The partnership supported early growth of astaxanthin as a popular ingredient for eye health applications.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• DSM-Firmenich: Global science-based ingredient company offering vitamins, nutraceutical APIs, and personalized nutrition solutions at scale. Overlaps with Valensa across dietary supplement and functional food categories but with vastly broader portfolio and R&D resources.
• Kerry Group: Global taste and nutrition company supplying ingredient systems to food, beverage, and supplement manufacturers. Comparable B2B ingredient model and clinical/health positioning but with broader portfolio including flavors, proteins, and functional ingredients.
• Cargill: Privately held global food and ingredient supplier with growing health and nutrition business spanning sweeteners, proteins, and specialty botanicals. Adjacent competitor in functional ingredient supply to supplement and food manufacturers.
• Glanbia Nutritionals: Global nutrition solutions provider offering proteins, pre/probiotics, and specialty ingredients to supplement and functional food manufacturers. Comparable customer base and B2B ingredient sales motion, with much broader product breadth.
• ADM (Archer Daniels Midland): Global nutrition and agricultural ingredient supplier with significant presence in botanical extracts, natural colors, and plant-based proteins. Competes with Valensa in functional food and supplement ingredient categories and has substantially larger scale and global reach.

Direct peers

• Naturex (Givaudan): Specialized botanical extracts supplier (now part of Givaudan) serving nutraceutical, food, and personal care markets with standardized plant-based ingredients. Highly comparable to Valensa's botanical extract portfolio, supercritical extraction capabilities, and clinical-substantiation approach.
• Kemin Industries: Privately held ingredient manufacturer specializing in plant-based bioactives, antioxidants, and specialty ingredients for human and animal nutrition. Comparable B2B ingredient model, proprietary extraction technologies, and vertically integrated supply chain for crops like rosemary, marigold, and oregano.
• Indena: Italian-based specialty botanical extracts manufacturer serving pharmaceutical and nutraceutical markets with standardized, clinically studied plant-derived ingredients. Highly comparable to Valensa on botanical extraction IP, clinical evidence emphasis, and B2B sales to health and wellness brands.
• PLT Health Solutions: B2B ingredient supplier focused on clinically substantiated, branded botanical and marine-sourced ingredients for dietary supplements and functional foods. Direct overlap with Valensa on branded, evidence-led ingredients sold to supplement brand customers.
• DolCas Biotech: Specialty botanical extract manufacturer serving nutraceutical and functional food markets with branded, clinically researched ingredients. Comparable positioning as a science-backed, smaller-scale botanical extract specialist competing with larger diversified players.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ValensaInternational
• LinkedInlinkedin.com/company/valensa-international

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valensa International